Americans are okay with gene-editing embryos to create healthier babies
The US public approves of gene-tailored babies but fears that the wealthy will use the technology first, leading to inequality.
The survey: The Pew Research Center asked 2,537 US adults how they felt about changing the genetic characteristics of babies using gene-editing tools.
Wide public support: Surprise. Seven out of 10 people said they think changing a baby’s genes is an appropriate use of technology, but only if it’s to treat or avoid a serious disease.
But only for healthy tots: When asked, only 20 percent thought making “more intelligent” humans would be acceptable. Most believed that using gene editing to increase intelligence would be taking things “too far.”
Top fear: Americans may be generally okay with genetically modified babies, but they still think negative results are more likely than positive ones. Survey respondents ranked inequality as their top worry. More than half think it’s “very likely” that gene-edited babies will only be available to the wealthy.
Deep Dive
Biotechnology and health
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Tiny faux organs could crack the mystery of menstruation
Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.
How AI can help us understand how cells work—and help cure diseases
A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.